Thousand Oaks-based Amgen Inc. and Allergan plc, headquartered in Dublin, Ireland, announced two biosimilar drugs for cancer treatment which the companies co-developed are for sale in the United States as of July 19....

Subscribe to get the full story.


Are you a subscriber? Sign In